# X4 Pharmaceuticals (XFOR) — News

XFOR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/xfor/news

## Recent headlines

- [OFCOM: Decided to focus the remainder of investigation on X's compliance with its illegal content and complaints and reporting duties](https://www.ainvest.com/news/ofcom-decided-focus-remainder-investigation-compliance-illegal-content-complaints-reporting-duties-2610) — AInvest Wire, Oct 14, 2026
  The UK's communications regulator, Ofcom, has announced that it will focus the remainder of its investigation on X's compliance with its obligations regarding illegal content and complaints and reporting duties. This decision follows an ongoing review of the platform's adherence to the Online…
- [X4 Pharmaceuticals gets up to $150M sr debt facility](https://www.ainvest.com/news/x4-pharmaceuticals-150m-sr-debt-facility-2610) — AInvest Wire, Oct 8, 2026
- [X4 Pharmaceuticals - Expects phase 3 4ward trial enrollment by year-end 2026, topline data in H1 2028](https://www.ainvest.com/news/x4-pharmaceuticals-expects-phase-3-4ward-trial-enrollment-year-2026-topline-data-h1-2028-2610) — AInvest Wire, Oct 8, 2026
  X4 Pharmaceuticals (Nasdaq: XFOR) announced on September 8, 2026, that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding the design of its global 4WARD Phase 3 clinical trial for mavorixafor in the treatment of chronic neutropenia. Following a Type C meeting with…
- [X4 Pharmaceuticals secures up to $150 million senior debt facility with K2 HealthVentures](https://www.ainvest.com/news/x4-pharmaceuticals-secures-150-million-senior-debt-facility-k2-healthventures-2610) — AInvest Wire, Oct 8, 2026
- [X4 Pharma targets 4ward topline data in 1H 2028](https://www.ainvest.com/news/x4-pharma-targets-4ward-topline-data-1h-2028-2609) — AInvest Wire, Sep 8, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).